Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,852 | -7,352 | -5,585 | -3,868 | -2,084 |
| Depreciation Amortization | 5 | 18 | 13 | 9 | 4 |
| Accounts receivable | -368 | -3,856 | -3,213 | -1,834 | -591 |
| Accounts payable and accrued liabilities | -447 | -3 | -608 | -741 | -911 |
| Other Working Capital | -1,057 | -3,038 | -3,275 | -2,201 | -1,384 |
| Other Operating Activity | 995 | 3,920 | 3,730 | 2,451 | 1,258 |
| Operating Cash Flow | $-2,723 | $-10,311 | $-8,938 | $-6,185 | $-3,708 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-3 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,502 | 18,668 | 15,447 | 10,171 | 9,866 |
| Other Financing Activity | -286 | -974 | -690 | -502 | -250 |
| Financing Cash Flow | $28,217 | $17,694 | $14,757 | $9,669 | $9,616 |
| Beginning Cash Position | 11,119 | 3,739 | 3,739 | 3,739 | 3,739 |
| End Cash Position | 36,612 | 11,119 | 9,558 | 7,223 | 9,647 |
| Net Cash Flow | $25,494 | $7,380 | $5,819 | $3,484 | $5,908 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,723 | -10,311 | -8,938 | -6,185 | -3,708 |
| Capital Expenditure | N/A | -3 | N/A | N/A | N/A |
| Free Cash Flow | -2,723 | -10,314 | -8,938 | -6,185 | -3,708 |